Best practice guide for the treatment of REM sleep behavior disorder (RBD)

Journal of Clinical Sleep Medicine

Volumn 6, Issue 1, 2010, Pages 85-95

  Aurora, R Nisha ^a   Zak, Rochelle S ^a   Maganti, Rama K ^b   Auerbach, Sanford H ^c   Casey, Kenneth R ^d   Chowdhuri, Susmita ^d   Karippot, Anoop ^e,f   Ramar, Kannan ^g   Kristo, David A ^h   Morgenthaler, Timothy I ^g   Tracy, Sharon L ⁱ  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^f University of Louisville School of Medicine   (United States)

^g MAYO CLINIC   (United States)

^h UNIVERSITY OF PITTSBURGH   (United States)

ⁱ University of Pittsburgh ^*

Author keywords

Acetylcholinesterase inhibitor; Benzodiazepine; Carbamazepine; Clonazepam; Clozapine; Desipramine; L DOPA; Melatonin; Paroxetine; Pramipexole; REM sleep behavior disorder; Sleep related injury; Sodium oxybate; Synucleinopathy; Yi Gan San; Zopiclone

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHOLINESTERASE INHIBITOR; CLONAZEPAM; CLOZAPINE; DESIPRAMINE; DONEPEZIL; LEVODOPA; MELATONIN; OXYBATE SODIUM; PAROXETINE; PRAMIPEXOLE; RIVASTIGMINE; TEMAZEPAM; TRIAZOLAM; ZOPICLONE;

CHINESE MEDICINE; CLINICAL PRACTICE; DEGENERATIVE DISEASE; DEMENTIA; DISEASE EXACERBATION; GAIT DISORDER; HUMAN; PARASOMNIA; PROGNOSIS; REVIEW; SLEEP APNEA SYNDROME; SYSTEMATIC REVIEW; YI GAN SAN;

EID: 77749245945     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.27717     Document Type: Review

References (99)

1. Schenck CH, Bundlie SR, Ettinger MG, Mahowald MW. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 1986;9:293-308.
2. Phillips B, Ball C, Sackett D, et al. Oxford Centre for Evidence-Based Mediane-Levels of Evidence (March 2009). http://www.cebm.net/index.aspx?o = 1025.
3. Fitch K, Bernstein SJ, Aguilar MS, et al., eds. The RAND/UCLA Appropriateness Method User's Manual; 2000.
4. Morrison AR, Mann GL, Hendricks JC. The relationship of excessive exploratory behavior in wakefulness to paradoxical sleep without atonia. Sleep 1981;4:247-57.
5. Schenck CH, Mahowald MW. REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep 2002;25:120-38.
6. Chiu HFK, Wing YK, Chung DWS, Ho CKW. REM sleep behavior disorder in the elderly. Int J Geriat Psychiatry 1997;12:888-91.
7. Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 2000;123:331-9.
8. Chiu HFK, Wing YK, Lam LCW, et al. Sleep-related injury in the elderly - An epidemiological study in Hong Kong. Sleep 2000;23:1-5.
9. Ohayon MM, Caulet M, Priest RG. Violent behavior during sleep. J Clin Psychiatry 1997;58:369-76.
10. Cornelia CL, Nardine TM, Diederich NJ, Stebbins GT. Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease. Neurology 1998;51:526-9.
11. Boeve BF, Silber MH, Ferman TJ, et al. REM sleep behavior disorder and degenerative dementia: An assodation likely reflecting Lewy body disease. Neurology 1998;51:363-70.
12. Uchiyama M, lsse K, Tanaka K, et al. Incidental Lewy body disease in a patient with REM sleep behavior disorder. Neurology 1995;45:709-12.
13. Boeve BF, Silber MH, Saper CB, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007;130:2770-88.
14. Mahowald MW, Schenck CH, Bornemann MA. Pathophysiologic mechanisms in REM sleep behavior disorder. Cun Neurol Neurosci Rep 2007;7:167-72.
15. Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology 1996;46:388-93.
16. Iranzo A, Molinuevo JL, Santamaria J, et al. Rapid-eye movement sleep behaviour disorder as an early marker for a neurodegenerative disorder a descriptive study. Lancet Neurol 2006;5:572-7.
17. Schenck CH, Bundlie SR, Mahowald MW. REM Behavior Disorder (RBD): Delayed emergence of Parkinsonism and/or dementia in 65% of older men initially diagnosed with idiopathic RBD, and an analysis of the minimum and maximum tonic and/or phasic electromyographic abnormalities found during REM sleep. Sleep 2003;26(Abstract supplement):A316.
18. Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 2001;16:622-30.
19. Gjerstad MD, Boeve BF, Wentzel-Larsen T, Aarsland D, Larsen JP. Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson's disease over time. J Neurol Neurosurg Psychiatry 2008;79:387-91.
20. Gagnon J-F, Bedard M-A, Fantini ML, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology 2002;59:585-9.
21. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium. Neurology 2005;65:1863-72.
22. Gagnon J-F, Petit D, Fantini ML, et al. REM sleep behavior disorder and REM sleep without atonia in probable Alzheimer disease. Sleep 2006;29:1321-5.
23. Boesch SM, Frauscher B, Brandauer E, Wenning GK, Hogl B, Poewe W. Disturbance of rapid eye movement sleep in spinocerebellar ataxia type 2. Mov Disord 2006;21:1751-4.
24. Iranzo A, Santamaria J, Tolosa E. The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases. Sleep Med Rev 2009;13:385-401.
25. Iranzo A, Graus F, Clover L, et al. Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis. Ann Neurol 2006;59:178-82.
26. Zambelis T, Paparrigopoulos T, Soldatos CR. REM sleep behaviour disorder associated with a neurinoma of the left pontocerebellar angle. J Neurol Neurosurg Psychiatry 2002;72:821-2.
27. Gomez-Choco MJ, Iranzo A, Blanco Y, Graus F, Santamaria J, Saiz A. Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis. Mult Scler 2007;13:805-8.
28. Xi Z, Luning W. REM sleep behavior disorder in a patient with pontine stroke. Sleep Med 2009;10:143-6.
29. Bonakis A, Howard RS, Williams A. Narcolepsy presenting as REM sleep behaviour disorder. Clin Neurol Neurosurg 2008;110:518-20.
30. Dauvilliers Y, Rompré S, Gagnon J-F, Vendette M, Petit D, Montplaisir J. REM sleep characteristics in narcolepsy and REM sleep behavior disorder. Sleep 2007;30:844-9.
31. Ferri R, Franceschini C, Zucconi M, et al. Searching for a marker of REM sleep behavior disorder: Submentalis muscle EMG amplitude analysis during sleep in patients with narcolepsy/cataplexy. Sleep 2008;31:1409-17.
32. Fantini ML, Michaud M, Gosselin N, Lavigne G, Montplaisir J. Periodic leg movements in REM sleep behavior disorder and related autonomic and EEG activation. Neurology 2002;59:1889-94.
33. Iranzo A, Santamaria J. Severe obstructive sleep apnea/hypopnea mimicking REM sleep behavior disorder: development of a scoring method. Sleep 2005;28:203-6.
34. Parish JM. Violent dreaming and antidepressant drugs: or how paroxetine made me dream that I was fighting Saddam Hussein. J Clin Sleep Med 2007;3:529-31.
35. Schenck CH, Mahowald MW, Kim SW, O'Connor KA, Hurwitz TD. Prominent eye movements during nrem sleep and rem sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder. Sleep 1992;15:226-35.
36. Schutte S, Doghramji K. REM behavior disorder seen with Venlafaxine (Effexor). Sleep Res 1996;25:364.
37. Onofrj M, Thomas A, Nash JR, Wilson SJ, Potokar JP, Nutt DJ. Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism - Correspondence. Neurology 2003:61:1161.
38. Teman P, Tippman-Peikert M, Silber MH, Slocumb NL, Robert Auger R. Idiopathic rapid-eye movement sleep disorder: associations with antidepressants, psychiatric diagnoses, and other factors, in relation to age of onset. Sleep Med 2009;10:60-65.
39. Winkelman JW, James L. Serotonergic antidepressants are associated with REM sleep without atonia. Sleep 2004;27:317-21.
40. Iranzo A, Santamaria J. Bisoprolol-induced rapid eye movement sleep behavior disorder. Am J Med 1999;107:390-2.
41. Silber MH. REM sleep behavior disorder associated with barbiturate withdrawal. Sleep Res 1996;25:371.
42. American Academy of Sleep Medicine. International classification of sleep disorders 2nd ed.: Diagnostic and coding manual. Westchester, IL: American Academy of Sleep Medicine; 2005.
43. Iber C, Ancoli-lsrael S, Chesson A, Quan SF, for the American Academy of Sleep Medicine. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications 1st ed. Westchester, IL: American Academy of Sleep Medicine; 2007.
44. Kluge M, Schussler P, Steiger A. Duloxetine increases stage 3 sleep and suppresses rapid eye movement (REM) sleep in patients with major depression. Eur Neuropsychopharmacol 2007;17:527-31.
45. Eisensehr I, Linke R, Noachtar S, Schwarz J, Gildehaus JF, Tatsch K. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behavior disorder: comparison with Parkinson's disease and controls. Brain 2000;123:1155-60.
46. Eisensehr I, Linke R, Tatsch K, et al. Increased muscle activity during Rapid Eye Movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease and controls. Sleep 2003;26:507-12.
47. Gilman S, Koeppe RA, Chervin RD, et al. REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA. Neurology 2003;61:29-34.
48. Albin RL, Koeppe RA, Chervin RD, et al. Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology 2000;55:1410-2.
49. Takahashi T, Mitsuya H, Murata T, Murayama J, Wada Y. Opposite effects of SSRIs and tandospirone in the treatment of REM sleep behavior disorder. Sleep Med 2008;9:317-9.
50. Yamamoto K, Uchimura N, Habukawa M, et al. Evaluation of the effects of paroxetine in the treatment of REM sleep behavior disorder. Sleep Biol Rhythms 2006;4:190-2.
51. Ferini-Strambi L, Di Gioia MR, Castronovo V, Oldani A, Zucconi M, Cappa SF. Neuropsychological assessment in idiopathic REM sleep behavior disorder (RBD): Does the idiopathic form of RBD really exist? Neurology 2004;62:41-5.
52. Vendette M, Gagnon JF, Decary A, et al. REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia. Neurology 2007;69:1843-9.
53. Ferman TJ, Boeve BF, Smith GE, et al. REM sleep behavior disorder and dementia: Cognitive differences when compared with AD. Neurology 1999;52:951-7.
54. Culebras A, Moore JT. Magnetic resonance findings in REM sleep behavior disorder. Neurology 1989;39:1519-23.
55. Husain A, Miller PP, Carwile ST. REM sleep behavior disorder: potential relationship to post-traumatic stress disorder. J Clin Neurophysiol 2001;18:148-57.
56. Lapierre O, Montplaisir J. Polysomnographic features of REM sleep behavior disorder: Development of a scoring method. Neurology 1992;42:1371-4.
57. Mahowald MW, Schenck CH. Status dissociatus - a perspective on states of being. Sleep 1991;14:69-79.
58. Manni R, Terzaghi M. REM behavior disorder associated with epileptic seizures. Neurology 2005;64:883-4.
59. Massironi G, Galluzzi S, Frisoni GB. Drug treatment of REM sleep behavior disorders in dementia with Lewy bodies. Int Psychogeriatr 2003;15:377-83.
60. Schenck CH, Boyd JL, Mahowald MW. A parasomnia overlap disorder involving sleepwalking, sleep terrors, and REM sleep behavior disorder in 33 polysomnographically confirmed cases. Sleep 1997;20:972-81.
61. Schenck CH, Hurwitz TD, Mahowald MW. REM sleep behaviour disorder: an update on a series of 96 patients and a review of the world literature. J Sleep Res 1993;2:224-31.
62. Schenck CH, Mahowald MW. Injurious sleep behavior disorders (parasomnias) affecting patients on intensive care units. Intensive Care Med 1991;17:219-24.
63. Sforza E, Krieger J, Petiau C. REM sleep behavior disorder: clinical and physiopathological findings. Sleep Med Rev 1997;1:57-69.
64. Wing YK, Lam SP, Li SX, et al. REM sleep behaviour disorder in Hong Kong Chinese: clinical outcome and gender comparison. J Neurol Neurosurg Psychiatry 2008;79:1415-6.
65. Bokey K. Conversion disorder revisited: severe parasomnia discovered. Aust N Z J Psychiatry 1 993;27:694-8.
66. Kimura K, Tachibana N, Kohyama J, Otsuka Y, Fukazawa S, Waki R. A discrete pontine ischemic lesion could cause REM sleep behavior disorder. Neurology 2000;55:894-5.
67. Kumru H, Santamaria J, Tolosa E, et al. Rapid eye movement sleep behavior disorder in parkinsonism with PARKIN mutations. Ann Neurol 2004;56:599-603.
68. Mortis L, Schwartz RS, Cistulli PA. REM sleep behaviour disorder: a treatable cause of falls in elderly people. Age Ageing 1997;26:43-44.
69. Provini F, Vetrugno R, Pastorelli F, et al. Status dissociatus after surgery for tegmental ponto-mesencephalic cavemoma: a state-dependent disorder of motor control during sleep. Mov Disord 2004;19:719-23.
70. Thomas M, Moore K. Falling asleep. Age Ageing 2004;33:636-7.
71. Hickey MG, Demaerschalk BM, Caselli RJ, Parish JM, Wingerchuk DM. "Idiopathic" Rapid-eye-movement (REM) sleep behavior disorder is associated with future development of neurodegenerative disorders. Neurologist 2007;13:98-101.
72. Personal communication from Schenck CH.
73. Schenck CH, Mahowald MW. A Polysomnographic, neurologic, psychiatric, and clinical outcome report on 70 consecutive cases with REM sleep behavior disorder (RBD): sustained clonazepam efficacy in 89.5% of 57 treated patients. Clev Clin J Med 1990;57(Suppl):S9-S23.
74. http://www.pdr.net/druginformation/DocumentSearchn-Local.aspx?DocumentlD= 69201150&DrugName=Klonopin%20Tablets.
75. Schenck CH, Milner DM, Hurwitz TD, Bundlie SR, Mahowald MW. A Polysomnographic and clinical report on sleep-related injury in 100 adult patients. Am J Psychiatry 1989;146:1166-73.
76. Schenck CH, Mahowald MW. Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. Am J Med 1996;100:333-7.
77. Mahowald MW, Schenck CH. REM sleep parasomnias. In: Kryger MH, Roth T, Dement WC, eds. Principles and practice of sleep medicine 4th ed. Philadelphia: Elsevier Saunders; 2005:897-916.
78. Anderson KN, Shneerson JM. Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam. J Clin Sleep Med 2009;5:235-9.
79. Ozekmekci S, Apaydin H, Kilic E. Clinical features of 35 patients with Parkinson's disease displaying REM behavior disorder. Clin Neurol Neurosurg 2005;107:306-9.
80. Schuld A, Kraus T, Haack M, Hinze-Selch D, Pollmacher T. Obstrudive sleep apnea syndrome induced by clonazepam in a narcoleptic patient with REM-sleep-behavior disorder. J Sleep Res 1999;8:321-2.
81. Kunz D, Bes F. Melatonin effects in a patient with severe REM sleep behavior disorder: case report and theoretical considerations. Neuropsychobiology 1997;36:211-4.
82. Kunz D, Bes F. Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation. Mov Disord 1999;14:507-11.
83. Takeuchi N, Uchimura N, Hashizume Y, et al. Melatonin therapy for REM sleep behavior disorder. Psychiatr Clin Neurosci 2001;55:267-9.
84. Boeve BF, Silber MH, Ferman TJ. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med 2003;4:281-4.
85. Anderson KN, Jamieson S, Graham AJ, Shneerson JM. REM sleep behavior disorder treated with melatonin in a patient with Alzheimer's disease. Clin Neurol Neurosurg 2008;110:492-5.
86. Fantini ML, Gagnon JF, Filipini D, Montplaisir J. The effects of pramipexole in REM sleep behavior disorder. Neurology 2003;61:1418-20.
87. Schmidt MH, Koshal VB, Schmidt HS. Use of pramipexole in REM sleep behavior disorder: results from a case series. Sleep Med 2006;7:418-23.
88. Kumru H, Iranzo A, Carrasco E, et al. Lack of effects of pramipexole on REM sleep behavior disorder in Parkinson disease. Sleep 2008;31:1418-21.
89. Tan A, Salgado M, Fahn S. Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa. Mov Disord 1996;11:214-6.
90. Garcia-Borreguero D, Caminero AB, de la Llave Y, et al. Decreased phasic EMG activity during rapid eye movement sleep in treatment-naive Parkinson's disease: effects of treatment with levodopa and progression of illness. Mov Disord 2002;17:934-41.
91. Rye DB. Contributions of the pedunculopontine region to normal and altered REM sleep. Sleep 1997;20:757-88.
92. Moraes WA, Poyares DR, Guilleminault C, Ramos LR, Bertolucd PHF, Tufik S. The effect of donepezil on sleep and REM sleep EEG in patients with Alzheimer disease: A double-blind placebo-controlled study. Sleep 2006;29:199-205.
93. Ringman JM, Simmons JH. Treatment of REM sleep behavior disorder with donepezil: A report of three cases. Neurology 2000;55:870-1.
94. Grace JB, Walker MP, McKeith I. A comparison of sleep profiles in patients with dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry 2000;15:1028-33.
95. Maclean LE, Collins CC, Byrne EJ. Dementia with Lewy bodies treated with rivastigmine: Effects on cognition, neuropsychiatric symptoms, and sleep. Int Psychogeriatr 2001;13:277-88.
96. Shinno H, Kamei M, Nakamura Y, lnami Y, Horiguchi J. Successful treatment with Yi-Gan San for rapid eye movement sleep behavior disorder. Prog Neuropsychoparmacol Biol Psychiatry 2008;32:1749-51.
97. Bamford CR. Carbamazepine in REM sleep behavior disorder. Sleep 1993;16:33-34.
98. Schenck CH, Bundlie SR, Patterson AL, Mahowald MW. Rapid eye movement sleep behavior disorder: a treatable parasomnia affecting older adults. JAMA 1987;257:1786-9.
99. Abad VC, Guilleminault C. Review of rapid eye movement behavior sleep disorders. Curr Neurol Neurosci Rep 2004;4:157-63.